XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating activities:    
Net loss $ (10,353) $ (19,888)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 8,931 16,573
Depreciation and amortization 3,600 3,821
Amortization of right-of-use assets 1,340 1,402
Revaluation of contingent consideration to estimated fair value 46 319
Amortization of premium and accretion of discount on short-term marketable securities, net 837 1,451
Other non-cash operating activities (7) 0
Changes in operating assets and liabilities:    
Accounts receivable (6,640) (9,199)
Inventory (2,674) (1,274)
Prepaid and other assets (2,784) 108
Operating leases liabilities, net (1,483) (1,372)
Accounts payable 377 (2,897)
Accrued compensation (24,082) (4,820)
Accrued and other liabilities 6,308 557
Change in deferred taxes 0 (93)
Net cash used in operating activities (26,584) (15,312)
Investing activities:    
Purchases of short-term marketable securities (52,472) (57,746)
Maturities of short-term marketable securities 55,427 86,893
Additions of capital expenditures (1,630) (1,487)
Net cash provided by investing activities 1,325 27,660
Financing activities:    
Proceeds from issuance of common stock under employee stock purchase plan 873 532
Taxes paid related to net share settlement of restricted stock units (3,065) (668)
Proceeds from exercise of stock options 3,049 8
Payment of contingent consideration (1,500) (625)
Repurchase and retirement of common stock 0 (522)
Net cash used in financing activities (643) (1,275)
Effect of exchange rate changes on cash and cash equivalents (77) 26
Net (decrease) increase in cash, cash equivalents and restricted cash (25,979) 11,099
Cash, cash equivalents and restricted cash at beginning of period 115,274 82,783
Cash, cash equivalents and restricted cash at end of period $ 89,295 $ 93,882